This site uses cookies to ensure the best viewing experience for our readers.
Cannabis Company InterCure Sells Part of Regenera Pharma Stake

Cannabis Company InterCure Sells Part of Regenera Pharma Stake

InterCure will sell 1.35% of Regenera for a profit of almost $1 million, leaving it with a 12.27% stake

Tzally Greenberg | 10:09  11.03.2019
Israel-based medical cannabis company InterCure Ltd., chaired by former Israeli Prime Minister Ehud Barak, is selling 1.35% of its stake in regenerative therapy company Regenera Pharma Ltd. In a Sunday filing to the Tel Aviv Stock Exchange, InterCure stated it expects to net a profit of $988,000 from the sale, which reflects a valuation of $94 million for Regenera.

InterCure will remain with a 12.27% stake in Regenera following the deal. The expected profit is higher than the revenues InterCure reported for the first six months of 2018 (NIS 3.1 million, or under $1 million), but InterCure's stock shot up by over 500% since Barak was appointed in September, giving the company a market capitalization of NIS 994 million, or $274 million.

Regenera, founded in 2008 and based in Israeli town Ness Ziona, is a clinical stage company developing drugs for the treatment of optic nerve neuropathies. The company raised $30 million to date. Marius Nacht, the co-founder of Nasdaq-listed network and cloud security provider Check Point Software Technologies Ltd., owns 24% of the company via his aMoon fund.

Cannabis. Photo: Shutterstock Cannabis. Photo: Shutterstock Cannabis. Photo: Shutterstock

share on facebook share on twitter share on linkedin share on whatsapp share on mail